Genenta Science S.p.A. Marketable Securities (Current)
Genenta Science S.p.A. (GNTA) had Marketable Securities (Current) of EUR 22.62 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-04-01
- 2025-12-31: Marketable Securities, Current 22.62M EUR.
- 2025-06-30: Marketable Securities, Current 12.49M EUR.
- 2024-12-31: Marketable Securities, Current 8.08M EUR.
- 2024-06-30: Marketable Securities, Current 10.72M EUR.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-12-31 | 22.62M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 12.49M EUR 6-K · filed 2025-10-10 |
| 2024-12-31 | 8.08M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 10.72M EUR 6-K · filed 2024-10-29 |
| 2023-12-31 | 15.08M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 10.00M EUR 6-K · filed 2023-10-20 |